cucurbitacin b은 임신 중 안전한가요?
No EU Annex II/III listing or harmonised CLP (no H360/H361 found). Peer‑reviewed studies show biologic activity and developmental effects in invertebrates (Drosophila) and multiple cytotoxic/anti‑proliferative effects in mammalian cell and cancer models, but I found no mammalian reproductive/developmental teratology studies showing fetal malformation in rodents or a harmonised reproductive classification — so classify as a structural/class concern (triterpenoid cytotoxin) rather than confirmed reproductive toxicant. Key sources: PubMed Drosophila developmental study and reviews showing potent bioactivity/cytotoxicity.
임신 중 cucurbitacin b 대체 안전 성분 | VeriMom
Related ingredients
Frequently asked questions
- cucurbitacin b은 임신 중 안전한가요?
- No EU Annex II/III listing or harmonised CLP (no H360/H361 found). Peer‑reviewed studies show biologic activity and developmental effects in invertebrates (Drosophila) and multiple cytotoxic/anti‑proliferative effects in mammalian cell and cancer models, but I found no mammalian reproductive/developmental teratology studies showing fetal malformation in rodents or a harmonised reproductive classification — so classify as a structural/class concern (triterpenoid cytotoxin) rather than confirmed reproductive toxicant. Key sources: PubMed Drosophila developmental study and reviews showing potent bioactivity/cytotoxicity.
- cucurbitacin b은 모유 수유 중 안전한가요?
- Same basis as pregnancy: biological activity and cytotoxicity in vitro and in vivo cancer models raise a plausible concern for systemic effects if absorbed, but there is no direct evidence of transfer into human milk or documented nursing-infant adverse outcomes. No harmonised CMR classification found to elevate hazard to h≥2.
- cucurbitacin b은 아기 피부에 안전한가요?
- No infant‑specific toxicity data. Because cucurbitacin B is a biologically active, low‑molecular‑weight triterpenoid with demonstrated cellular toxicity, assign a class/structural concern (h=1). Dermal absorption data are lacking; immature infant skin increases exposure potential so exposure score is increased (+1) to e=2 for 0–3 yr old skin. No infant dermal irritation/systemic developmental studies were found.
- VeriMom은 cucurbitacin b을 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 cucurbitacin b을 67/100 (중간 위험)로 평가합니다.
- 임신 중 cucurbitacin b 대체 안전 성분은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.